Xcure Surgical
A MedTech startup developing the next generation of patient-specific 3D printed implants and surgical guides for complex bone reconstructions in orthopedics, maxillofacial, thoracic, and spinal surgery.
- CEO / Founder
- Alba Gonzalez Alvarez
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $350K
- Latest Round
- Grant
- Key Investors
- European Commission (Marie Skłodowska-Curie Actions), Spanish Ministry of Science and Innovation, Universidad Carlos III de Madrid (UC3M), HealthTech Capital, Portfolia
Technology & Products
Key Products
["Custom 3D Printed Bone Implants (Titanium and PEEK)","Virtual Surgical Planning (VSP) Services","Patient-Specific Surgical Guides (PSI)","Custom Mandibular Distraction Devices"]
Technological Advantage
Proprietary digital workflow that integrates virtual surgical planning with multi-material additive manufacturing (metal and polymer), allowing for the treatment of cases where standard off-the-shelf implants fail.
Differentiation
Value Proposition
Provides high-precision, personalized surgical solutions for 'unsolvable' bone defects, significantly reducing operation time and improving patient outcomes through bio-inspired anatomical fit.
How They Differentiate
Xcure differentiates through a 'clinical-first' approach, utilizing bio-inspired lattice structures that mimic natural bone density and porosity. Unlike mass-market providers, they focus on 'unsolvable' complex bone defects using a proprietary digital workflow that integrates the founder's deep clinical experience from the NHS with advanced multi-material additive manufacturing.
Market & Competition
Target Customers
Specialized surgeons (orthopedic, maxillofacial, and neurosurgeons), hospitals, and specialized surgical centers treating complex bone defects.
Industry Verticals
["Medical Devices","Healthcare","Additive Manufacturing (3D Printing)","Biomedical Engineering"]
Competitors
Materialise NV; 3D Systems (Healthcare Division); Stryker (Patient Specific Solutions)
Growth & Milestones
Growth Metrics
Transitioned from academic research to commercial startup in 2024; currently in the clinical validation and early commercialization phase.
Major Milestones
["Winner of the TCT Women in 3D Printing Innovator Award 2023","Official incorporation of Xcure Surgical in early 2024","Recipient of the Spanish National Design Award 2024 (Young Designers Category)","Finalist for the TCT Women in 3D Printing Innovator Award 2025"]
Notable Customers
Hospital General Universitario Gregorio Marañón; Morriston Hospital (NHS UK - Clinical Research Phase)